1 Modeling antibiotic resistance in populations: from deterministic to stochastic to agent-based models. Laura TEMIME G Thomas, PY Boëlle, D Guillemot.

Slides:



Advertisements
Similar presentations
Hospital-acquired and community-acquired MRSA in hospitals
Advertisements

NOSOCOMIAL ANTIBIOTIC RESISTANT ORGANISMS
Mathematical Modelling of Healthcare Associated Infections Theo Kypraios Division of Statistics, School of Mathematical Sciences
Disease emergence in immunocompromised populations Jamie Lloyd-Smith Penn State University.
Development of Healthcare- Associated Infections: Role of the Built Environment James P. Steinberg, MD Division of Infectious Diseases Emory University.
The Resistance Problem PRSP = Penicillin Resistant Strep. pneumoniae QRSP = Quinolone Resistant Strep. pneumoniae MRSA = Methicillin Resistant Staph.
BETHLEHEM UNIVERSITY Second Neonatal Gathering Fall 2007.
Do Health Care Regulation and Physician-Industry Interaction Influence Antibiotic Resistance Rates? The Example of Antimicrobial Prescribing and Dispensing.
Mathematical Modeling of the Life Cycle of Toxoplasma gondii A Sullivan, W Jiang, F Agusto, S Bewick, C Su, M Gilchrist, M Turner, and X Zhao 1.
Modeling the Ebola Outbreak in West Africa, 2014 August 11 th Update Bryan Lewis PhD, MPH Caitlin Rivers MPH, Stephen.
Presentation Topic : Modeling Human Vaccinating Behaviors On a Disease Diffusion Network PhD Student : Shang XIA Supervisor : Prof. Jiming LIU Department.
Evaluating Whether Interventions on the Use of Antibiotics Work to Decrease Resistance Chris Ford Regina Joice 1/18/08.
Joe Dinius ECE Oct  Introduction  Review of the Literature  Hypotheses  Model Description  Parameters  Results  Sensitivity Analysis.
Mathematical models for interventions on drug resistance Hsien-Ho Lin.
Insights from economic- epidemiology Ramanan Laxminarayan Resources for the Future, Washington DC.
The role of cross-immunity and vaccines on the survival of less fit flu-strains Miriam Nuño Harvard School of Public Health Gerardo Chowell Los Alamos.
1 The epidemic in a closed population Department of Mathematical Sciences The University of Liverpool U.K. Roger G. Bowers.
Modeling the SARS epidemic in Hong Kong Dr. Liu Hongjie, Prof. Wong Tze Wai Department of Community & Family Medicine The Chinese University of Hong Kong.
What can we learn from individual- level studies of antibiotic resistance? Molly Franke EPI 502 January 17, 2008.
Surprising Victories Against Old Foes: New Hope for Prevention and Control of Healthcare- Associated MRSA Infections John A. Jernigan, MD, MS Division.
MRSA and VRE. MRSA  1974 – MRSA accounted for only 2% of total staph infections  1995 – MRSA accounted for 22% of total staph infections  2004 – MRSA.
Epidemiology and Control of Methicillin-Resistant Staphylococcus aureus in hospitals Maria Kapi,MD Registrar of Medical Microbiology Laiko General Hospital.
MRSA and VRE. MRSA  1974 – MRSA accounted for only ____of total staph infections  1995 – MRSA accounted for _____ of total staph infections  2004 –
Pandemic Influenza Preparedness Kentucky Department for Public Health Department for Public Health.
©2008, Promega Corporation. All rights reserved. Emerging Pathogens Community-Associated Methicillin- Resistant Staphylococcus aureus.
Chapter 10: Restricting antibiotic use and optimizing dosing.
Community- Associated MRSA Maha Assi, MD, MPH. MRSA Hits the Media October 16, 2007 October 16, 2007 Lead story on MRSA Lead story on MRSA “superbug killing.
Preventing Multidrug-Resistant Organisms (MDROs) What the Direct Caregiver Should Know Prepared by: Ann Bailey, RNC, BSN, CIC Joanne Dixon, RN, MN, CIC.
Indication for Otitis Media FDA Vaccine and Related Biologicals Advisory Committee Meeting May 21, 2002 Pneumococcal 7-Valent Conjugate Vaccine (Diphtheria.
Methods to Study and Control Diseases in Wild Populations Steve Bellan, MPH Department of Environmental Sci, Pol & Mgmt University of California at Berkeley.
Biological Hazards Disease in Developed and Developing Countries.
Simulacra & Simulation (& Health Care-Associated Infections) Michael Rubin, MD, PhD Section Chief, Epidemiology VA Salt Lake City Health Care System.
Epidemiology Tools and Methods Session 2, Part 1.
Epidemiology.
Emerging Infectious Disease: A Computational Multi-agent Model.
Recommendation on prudent use of antimicrobial agents in human medicine – Slovenian experiences Intersectoral Coordination Mechanism Prof. Milan Čižman,
Designs to determine the impact of Ab resistance How do we correctly measure the outcomes of antibiotic resistance?
National and International Spread of Antimicrobial Resistance: Clones and Genes Professor Alan Johnson, Health Protection Services - HPA.
Methicillin Resistant Staphylococcus aureus Exposure Assessment in a Burn Center Environment Cassandra Andrade, Space Grant Intern Kelly Reynolds, Ph.D.,
Evaluation of the resistance of bacterial pathogens of synopulmonary infections in children L.Chernyshova F.Lapiy National Medical Academy of Postgraduate.
Multivalent pneumococcal vaccines can increase the transmissibility and virulence of non-vaccine strains Eleanor Watkins, Caroline Buckee, Bridget Penman,
Informing disease control strategies using stochastic models S.
Ecdc.europa.eu Tommi Asikainen, Tubingen, 22 October 2008 European Centre for Disease Prevention and Control FUTURE DISEASE CHALLENGES IN EUROPE – where.
Why Canadian fur trappers should stay in bed when they have the flu: modeling the geographic spread of infectious diseases Lisa Sattenspiel Department.
IDO-Staph: An Ontology of Staphylococcus aureus Infectious Disease Albert Goldfain, Ph.D. Researcher, Blue Highway, Inc. Problems.
Stochastic colonization and extinction of microbial species on marine aggregates Andrew Kramer Odum School of Ecology University of Georgia Collaborators:
Created byInformation Design A Mathematical Model for the Impact of the Conjugate Vaccine on S. pneumoniae Vaccine and Non-vaccine serotypes Robertino.
Antimicrobial Resistance patterns among nosocomial gram negative bacilli by E-test and disc diffusion methods in Sina and Imam Hospital.
HANDling MRSA in Outpatients By Anne M. Hendricks What are the barriers to utilization of best practice guidelines to care for MRSA patients in the outpatient.
1 EPIDEMIOLOGY 200B Methods II – Prediction and Validity Scott P. Layne, MD.
Case Control Study Dr. Ashry Gad Mohamed MB, ChB, MPH, Dr.P.H. Prof. Of Epidemiology.
1 Environment and Sensor Networks US – France Workshop Guillaume Chelius ARES Project, INRIA October, , 2007.
Influenza epidemic spread simulation for Poland – A large scale, individual based model study.
CDC's Model for West Africa Ebola Outbreak Summarized by Li Wang, 11/14.
ESI workshop Stochastic Effects in Microbial Infection The National e-Science Centre Edinburgh September 28-29, 2010.
Introduction to decision analysis modeling Alice Zwerling, Postdoctoral fellow, JHSPH McGill TB Research Methods Course July 7, 2015.
Types of Studies. Aim of epidemiological studies To determine distribution of disease To examine determinants of a disease To judge whether a given exposure.
GENOMICS TO COMBAT RESISTANCE AGAINST ANTIBIOTICS IN COMMUNITY-ACQUIRED LRTI IN EUROPE (GRACE) H. Goossens (Coordinator), K. Loens (Manager), M. Ieven.
Epidemiology. Classically speaking Classically speaking EPI DEMO LOGOS Upon,on,befall People,population,man the Study of The study of anything that happens.
KJO Hospital Infection Control Local 2176/2097 Ross Ibabao/ICCo.
How I deal with an outbreak? Prof Bertrand SOUWEINE Medical ICU Clermont-Ferrand France ISICEM March 2009.
GLOBAL GUIDELINES FOR THE PREVENTION OF SURGICAL SITE INFECTION: An introduction Launched 3 November 2016.
Number of S, I and R to six antibiotics
Table 1 Groups of subjects in a study of the association between antibiotic use and colonization with resistant pneumococci. From: Measuring and Interpreting.
Vaccine Efficacy, Effectiveness and Impact
CRE prevalence among patients with no prior history of carriage
GLOBAL GUIDELINES FOR THE PREVENTION OF SURGICAL SITE INFECTION: An introduction Launched 3 November 2016.
Multistrain Epidemic Dynamics on Dynamical Networks
MRSA=Methicillin resistant Staphylococcus aureus
Pneumococcal conjugate vaccines: overview of a decade from Kuwait
Presentation transcript:

1 Modeling antibiotic resistance in populations: from deterministic to stochastic to agent-based models. Laura TEMIME G Thomas, PY Boëlle, D Guillemot L Opatowski, Y Pannet

2 Modeling antibiotic resistance in populations Why model resistance? To achieve better understanding of underlying processes in resistance selection To predict future changes To evaluate control measures such as: – Reduction of antibiotic consumption in the community – Hand washing, systematic isolation or use of rapid diagnostic tests in hospitals

3 Different modeling approaches Available approaches for modeling antibiotic resistance selection in a population: In large communities (e.g. country): – Compartmental deterministic models  Good prediction of the average behavior In smaller settings (e.g. schools, hospitals): – Compartmental stochastic models  Information on the variability of processes – Agent-based models  Data on the individual level

4 Presentation outline Modeling pneumococcal resistance to penicillin using a compartmental model: – Deterministic model – Stochastic model  Several papers between 2003 and 2006 Modeling the selection and spread of antibiotic resistance in hospital settings: – Individual-based model  Preliminary results, work in progress

5 I- Modeling the selection of pneumococcal resistance to penicillin in France A deterministic model (Temime L, Boëlle PY, Courvalin P, Guillemot D; Emerg Infect Dis, 2003)

6 Context overview S. pneumoniae: – Human pathogen (otitis, pneumonia, meningitis)  3-5 million deaths / year worldwide – Frequent asymptomatic carriage  Up to 40% carriers among children – Widespread antibiotic resistance  In France over 60% of strains exhibit decreased sensitivity to penicillin  frequently observed multiple resistance

7 A specific resistance mechanism S. pneumoniae resistance to penicillin:  Progressive decrease of sensitivity (MIC)

8 A specific model Objective = combining two levels for pneumococcal resistance selection: – Intra-individual evolution of strains  reproducing the resistance mechanism – Inter-individual transmission of strains Model characteristics: – Compartmental deterministic model (partial differential equations) – Progressive increase of resistance levels  Colonized compartments structured by MIC (continuous)

9 A specific model: illustration Unexposed to antibioticsExposed to antibiotics Genetic events progressive MIC increase

10 Model parameters Parameters which may be controlled Frequency and duration of  -lactam exposure Parameters which are documented in the literature Frequency and duration of pneumococcal colonization Resistance mechanism Parameters which require calibration Transmissibility of pneumococci in a population 8 days1 tmt / 2 yrs 2.2 months

11 Effects of antibiotic exposure Colonization may persist with probability: MIC may increase due to genetic events, according to the law:  (m) = (d)=(d)=

12 Validation of model predictions Model predictionsCNRP data (87-97) 1987 : mostly antibiotic sensitive strains 1997 : bimodal distribution of MICs

13 Applications of this deterministic model Predictions for N. meningitidis: – Differences in resistance levels of pneumococci and meningococci can be explained by their natural histories of colonization alone – High resistance levels expected in years to come Pneumococcal conjugate vaccination: – Short-term impact on carriage and resistance – BUT expected re-increase in resistance in the long-term, due to replacement of vaccine strains by non-vaccine strains which will become resistant (Temime L, Boëlle PY, Valleron AJ, Guillemot D; Epid Infect, 2005) (Temime L, Guillemot D, Boëlle PY; Antimicrob Agents Chemother, 2004)

14 II- Modeling the selection of pneumococcal resistance to penicillin A stochastic model (Temime L, Boëlle PY, Courvalin P, Guillemot D; Emerg Infect Dis, 2003) (Temime L, Boëlle PY, Thomas G; Math Pop Studies, 2005)

15 Motivation Shortcomings of the deterministic model: – Averaged predictions – No information on variability – Identical predictions regardless of population size  Developing a stochastic version of the model will allow: – More realism in the description – Better predictions in small populations – Information on the variability of predicted phenomena

16 General principles Same compartmental model than in the deterministic setting But transitions between compartments are considered random  Associated transition probabilities For large population sizes, the deterministic solution approximates the mean stochastic epidemics

17 Results in a town-like community (1000 individuals) Time before 20% of strains will have reached this MIC For a given MIC: Time before the first emergence of a strain with this MIC  Penicillin-resistant pneumococcal strains will emerge on average 20 years after the introduction of penicillin, but it may be years.

18 III- Modeling the selection of S. aureus multi-resistance in hospital settings (ICUs) An agent-based model

19 Context overview Staphylococcus aureus : – Human pathogen (skin infections, septicemia, endocarditis) – 10-40% asymptomatic carriers – Colonization duration?? Antibiotic resistance : – Widespread penicillin resistance – Methicillin resistance (MRSA) common in hospital settings since the 1960’s (30-50% of all strains) – Emergence of MRSA in the community in recent years

20 Some important questions What are the determinants for persistence of a staphylococcal strain in a hospital setting? Why aren’t NO-MRSA successful outside hospitals? Which context could allow for the successful introduction of CA-MRSA in hospitals? What would be the consequences?

21 Why an agent-based model? Individual-based or agent-based modeling has proved useful for: – Modeling epidemic spread in an urban network (Eubank et al., Nature, 2004) or even at a countrywide scale (Longini et al., Am J Epid, 2004) – Simulating healthcare activities in a hospital setting (Boelle et al., Comput Biom Res, 1998) – Modeling pathogen dissemination in an ICU (Hotchkiss et al., Crit Care Med, 2005) and interventions  Allows for more realism and easier description of individual behaviors

22 Model structure: hospital ward (ICU) Patient 1 Ward corridors / Staff room DoctorsNurses 1234 Patient 2Patient 3Patient … …… ROOMS …

23 Model structure: agents and agent characteristics Human AgentCharacteristicsEnvironment PatientLength of stay Healthcare burden Colonized ? → Colonizing strain, site of colonization Room Healthcare workerDaily task-list Hygiene compliance Colonized ? → Colonizing strain, site of colonization Affected patients

24 Model structure: agents and agent characteristics (2) AgentCharacteristicsEnvironment Micro-organismCarriage duration Transmissibility Conferred immunity and cross-immunity Colonized human agents Antimicrobial agentMechanism of action Efficacy on present micro-organisms Exposed human agents  Transmission of colonization through infectious contacts

25 First model outcomes (1) Real-time graphical display of the hospital ward: Follow-up of the geographical spread of micro-organisms

26 First model outcomes (2) Temporal changes in proportions of colonized individuals:

27 First model outcomes (3) Who colonized whom? History of transmission:

28 Perspectives for the ABM Lots of possible uses: – Educational tool – Assessment of control measures taking into account individual behaviors (non compliance) – Predictions for dominance in a two strain-environment (CA-MRSA and NO-MRSA) Disadvantages: – Not a mathematical model  no analytical expression available – Costly in simulation time – Large amount of data needed

29 Need for data: complex models require complex data

30 Need for data Data for model building (parameter values): – Micro-organism characteristics (duration of colonization, invasivity,...) – Human characteristics (daily activities and contacts, immunity status,...) – Resistance characteristics (mechanism of emergence, current susceptibility levels,...) Data for model validation: – Historical data on emergence and spread of resistant strains in specific settings  Allows comparison with model predictions

31 Specific needs for different kinds of models The amount of required data increases with model complexity: Compartmental models: – Mean characteristics in the population: duration and frequency of antibiotic exposure, infectious contact rate – Mean characteristics of the micro-organism: duration of colonization, susceptibility to antibiotic exposure – Resistance mechanism characteristics Agent-based models: – Similar characteristics at the individual level – Supplemental data on individual behaviors

32 Infectious contact rate Complex parameter which includes: – The frequency of inter-human contacts – The transmissibility of the micro-organism Estimation strategies: – Not directly observed in populations – Often calibrated to reflect observed colonization – May be estimated using MCMC methods from longitudinal data (Cauchemez et al., BMC Inf Dis, 2006) – Will be measured in hospital settings using “contact tracers” carried by staff and patients (MOSAR project, WP7)

33 Conclusions and perspectives

34 Conclusions Rising impact of the modeling approach to study antibiotic resistance selection over the last 15 years : – More published models – More cited by a wider audience Recent developments: more complex models which require more complex data  Antibiotic resistance modeling can only be satisfyingly achieved through a collaboration with microbiologists, physicians, etc.